Using the index as a starting point for our own research, we discovered that the companies most suited to deal with the ...

By Ludwig Burger (Reuters) -German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion ...

Bristol Myers Squibb has appointed Wendy Bartie as EVP, corporate affairs. Bartie started in the role this month, BMS said on ...

Bristol Myers Squibb didn’t want to choose between clinical expertise and financial know-how when selecting a new leader. | ...

President Donald Trump’s tariff regime may not be having the desired effect of bringing manufacturing back to the US yet, but ...

During a live event, Matthew Galsky, MD, discussed adjuvant and neoadjuvant treatment approaches for muscle-invasive bladder ...

Compared with chemotherapy alone, neoadjuvant nivolumab plus chemotherapy extends overall survival in patients with resectable non-small cell lung cancer.

Lots of people are doing great research all across the whole spectrum of rheumatoid arthritis, from hard-to-treat disease, to early disease, to severe disease, various forms of rheumatoid arthritis ...

In this video, Kevin Deane, MD, PhD, discusses rheumatoid arthritis prevention tips clinicians can share with patients.

Phosphodiesterase type 5 (PDE5) inhibitors like sildenafil citrate may prevent intrapartum fetal distress. The results contradict an earlier study that indicated benefits with PDE5 inhibitors; further ...

BioNTech has announced that it will be expanding its messenger RNA (mRNA) capabilities by acquiring CureVac for approximately ...